Clinical trial
A phase IV, open-label single-arm study investigating the pharmacokinetics and pharmacodynamics of the antiretroviral combination of rilpivirine and ritonavir-boosted darunavir in therapy-naive HIV-1 infected patients.
To see how well the study regime suppresses the HIV-1 virus after 48 weeks of therapy.
| Category | Value |
|---|---|
| Study start date | 2012-10-08 |